GRPI

GRUPO INTERNATIONAL INC by GRUPO International, Inc. (GRPI)

About GRUPO INTERNATIONAL INC by GRUPO International, Inc. (GRPI)

Grupo International, Inc. engages in development and marketing of a proposed vaccine designed to combat human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS). The company was founded on January 1, 1997 and is headquartered in Collingwood, Canada.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
1,000
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--

GRUPO INTERNATIONAL INC by GRUPO International, Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
1,000
Dividend yield
0.00%
Volume
--
Avg. volume
0
P/E ratio
--